The invention relates to solid forms of amorphous obeticholic acid of formula I with at least one pharmaceutically acceptable excipient, which may be selected from the group of polymers, saccharides, oligosaccharides, polysaccharides, fats, waxes or urea. The amorphous obeticholic acid is advantageously stabilized with hydroxypropyl methylcellulose (hypromellose, HPMC), hypromellose acetate succinate (HPMC AS) derivatives of polymethacrylate, (Eudragit E100, Eudragit L100, Eudragit S100), polyvinyl pyrrolidone (Povidone, PVP), copovidone (Kollidon) or copolymers of polyvinyl caprolactam - polyvinyl acetate - polyethylene glycol (Soluplus).
